pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
APL-1501
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Asieris Pharmaceuticals (USA) Inc
0 catalysts
Phase 2
APL-2302
Breast Cancer
Asieris Pharmaceuticals (USA) Inc
0 catalysts
Phase 1
APN-401
Head And Neck Squamous Cell Carcinoma (HNSC)
InvIOs GmbH
0 catalysts
Phase 1
APNmAb-005
← prev
page 57 of 271
next →
131
Pain89
Neurology1
Alzheimer's Disease
Aprinoia Therapeutics Inc
0 catalysts
Preclinical
APP-13002
Bacterial Conjunctivitis
Formosa Pharmaceuticals Inc
0 catalysts
Phase 2
APPA-02
Resistant Pseudomonas aeruginosa Infections
$ARMPArmata Pharmaceuticals, Inc.
0 catalysts
Phase 1
APR-1051
Breast Cancer
$APREAprea Therapeutics, Inc.
0 catalysts
Phase 2
APS-03118
Medullary Thyroid Cancer
Applied Pharmaceutical Science Inc
0 catalysts
Phase 2
APSA-02
Bacteremia
$ARMPArmata Pharmaceuticals, Inc.
0 catalysts
Preclinical
APT-002
Glioblastoma Multiforme (GBM)
Aptah Bio Inc
0 catalysts
Preclinical
APT-101
Idiopathic Pulmonary Fibrosis
APIE Therapeutics Inc
0 catalysts
Preclinical
APT-110
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
AptamiR Therapeutics Inc
0 catalysts
Phase 2
APTA-16
Myelodysplastic Syndrome (Preleukemia)
AptaBio Therapeutics Inc
0 catalysts
Preclinical
AQ-002
Asthma
Aquilon Pharmaceuticals SA
0 catalysts
Preclinical
AQ-003
Chronic Obstructive Pulmonary Disease (COPD)
Aquilon Pharmaceuticals SA
0 catalysts
Preclinical
AQ-004
Lung Cancer
Aquilon Pharmaceuticals SA
0 catalysts
Phase 1
AQ-280
Eosinophilic Esophagitis
Aqilion AB
0 catalysts
Preclinical
AR-170
Solid Tumor
Y-Biologics Inc
0 catalysts
Preclinical
ARB-1002
Pancreatic Cancer
Arbele Ltd
0 catalysts
ARBLI
ARBLI (LOSARTAN POTASSIUM)
1 INDICATIONS AND USAGE Arbli is an angiotensin II receptor blocker (ARB) ind…
Type-1 angiotensin II receptor
$SCNXScienture Holdings, Inc.
0 catalysts
Preclinical
ARBM-201
Acute Respiratory Distress Syndrome
Arbormed Co Ltd
0 catalysts
ARCALYST
ARCALYST (RILONACEPT)
Kiniksa Pharmaceuticals Corp
0 catalysts
Phase 2
ARCT-032
Cystic Fibrosis
$ARCTArcturus Therapeutics Holdings Inc.
0 catalysts
Phase 2
ARCT-165
Coronavirus Disease 2019 (COVID-19)
Seqirus Ltd
0 catalysts
Phase 1
ARCT-2304
Influenza A Virus, H5N1 Subtype Infections
$ARCTArcturus Therapeutics Holdings Inc.
0 catalysts
Phase 2
ARCT-810
Ornithine-Transcarbamylase Deficiency
$ARCTArcturus Therapeutics Holdings Inc.
0 catalysts
Phase 2
ARD-103
Refractory Acute Myeloid Leukemia
ARCE Therapeutics Inc
0 catalysts
ARFORMOTEROL TARTRATE INHALATION
ARFORMOTEROL TARTRATE INHALATION (ARFORMOTEROL TARTRATE INHALATION)
SLATE RUN PHARMA
0 catalysts
Preclinical
ARG-006
Hypoxic-Ischemic Encephalopathy
Argenica Therapeutics Ltd
0 catalysts
ARIKAYCE KIT
ARIKAYCE KIT (AMIKACIN SULFATE)
respiratory tract infectious disorder
Bacterial 70S ribosome
$INSMINSMED Inc
0 catalysts